Page last updated: 2024-08-22

diallyl disulfide and Peritoneal Neoplasms

diallyl disulfide has been researched along with Peritoneal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, J; Huang, WG; Liao, QJ; Su, Q; Tan, H; Zhao, J1

Other Studies

1 other study(ies) available for diallyl disulfide and Peritoneal Neoplasms

ArticleYear
Diallyl disulfide suppresses growth of HL-60 cell through increasing histone acetylation and p21WAF1 expression in vivo and in vitro.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:11

    Topics: Acetylation; Allyl Compounds; Animals; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p21; Disulfides; Garlic; Histones; HL-60 Cells; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Peritoneal Neoplasms; Random Allocation

2006